2023 Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey Group Activity survey office COVID-19 1st listed author Jakob R Passweg Journal Bone Marrow Transplant.
2023 Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas Group Lymphoma Working Party (LWP) 1st listed author Alberto Mussetti Journal Transplant Cell Ther.
2023 Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study Group Infectious Diseases Working Party (IDWP) Other society 1st listed author Dina Averbuch Journal Bone Marrow Transplant.
2023 Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2023 Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Raffaella Greco Journal Bone Marrow Transplant.
2023 Outcome of haematopoietic cell transplantation in children with lysosomal acid lipase deficiency: a study on behalf of the EBMT Inborn Errors Working Party Group Inborn Errors Working Party (IEWP) 1st listed author Su Han Lum Journal Bone Marrow Transplant.
2023 Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Sebastian Giebel Journal Bone Marrow Transplant.
2023 Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Anna Waszczuk-Gajda Journal Bone Marrow Transplant.
2023 Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation Group Chronic Malignancies Working Party (CMWP) 1st listed author Guillermo Ortí Journal Am J Hematol.
2023 Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Alexandros Spyridonidis Journal Hemasphere.
2023 Decision making on HSCT in patients with hemoglobinopathies; an EBMT Pediatric Diseases Working Party and Inborn Errors Working Party scenario-based survey on physicians' perspectives Group Inborn Errors Working Party (IEWP) Paediatric Diseases Working Party (PDWP) 1st listed author Hilda Mekelenkamp Journal Bone Marrow Transplant.
2023 Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey Group Infectious Diseases Working Party (IDWP) 1st listed author Moshe Yeshurun Journal Bone Marrow Transplant.